{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:12Z","timestamp":1786997892330,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2021.06.072","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:17:11Z","timestamp":1625271431000},"page":"4628-4640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4346-1045","authenticated-orcid":false,"given":"Chia-Yun","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9614-5922","authenticated-orcid":false,"given":"Julia A.","family":"Misplon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme E.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-6890","authenticated-orcid":false,"given":"Suzanne L","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2021.06.072_b0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.072_b0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00239-008-9119-z","article-title":"The evolutionary dynamics of human influenza B virus","volume":"66","author":"Chen","year":"2008","journal-title":"J Mol Evol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.072_b0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-3476(00)70097-7","article-title":"Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A\/Sydney) not contained in the vaccine","volume":"136","author":"Belshe","year":"2000","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.072_b0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","article-title":"The Pathway to a Universal Influenza Vaccine","volume":"47","author":"Paules","year":"2017","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.072_b0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/irv.12013","article-title":"Advances in the development of universal influenza vaccines","volume":"7","author":"Gilbert","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"12","key":"10.1016\/j.vaccine.2021.06.072_b0030","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/aje\/kwy145","article-title":"Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo","volume":"187","author":"Epstein","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.06.072_b0035","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1073\/pnas.1113342109","article-title":"Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza","volume":"109","author":"Arinaminpathy","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/j.vaccine.2021.06.072_b0040","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1128\/JVI.74.15.6800-6807.2000","article-title":"Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes","volume":"74","author":"Voeten","year":"2000","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2021.06.072_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virusres.2004.02.020","article-title":"Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes","volume":"103","author":"Rimmelzwaan","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2021.06.072_b0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/jb.89.1.170-174.1965","article-title":"Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus","volume":"89","author":"Schulman","year":"1965","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2021.06.072_b0055","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/iai.29.2.650-653.1980","article-title":"Heterotypic immunity to influenza in ferrets","volume":"29","author":"Yetter","year":"1980","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2021.06.072_b0060","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.152.4.1653","article-title":"Heterosubtypic immunity to influenza type A virus in mice: Effector mechanisms and their longevity","volume":"152","author":"Liang","year":"1994","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.072_b0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","article-title":"Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice","volume":"25","author":"Kreijtz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.072_b0070","series-title":"Vaccines 93","first-page":"137","article-title":"Injection of expression vectors containing viral genes induces cellular, humoral, and protective immunity","author":"Rhodes","year":"1993"},{"issue":"5102","key":"10.1016\/j.vaccine.2021.06.072_b0075","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.072_b0080","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nature Med"},{"issue":"46\u201347","key":"10.1016\/j.vaccine.2021.06.072_b0085","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2021.06.072_b0090","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1586\/erv.10.123","article-title":"Cross-protective immunity to influenza A viruses","volume":"9","author":"Epstein","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"47","key":"10.1016\/j.vaccine.2021.06.072_b0095","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1016\/j.vaccine.2009.08.053","article-title":"Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses","volume":"27","author":"Price","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.072_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013162","article-title":"Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses","volume":"5","author":"Price","year":"2010","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.072_b0105","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.2105\/AJPH.2012.301137","article-title":"The burden of influenza B: a structured literature review","volume":"103","author":"Glezen","year":"2013","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.072_b0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7774\/cevr.2019.8.1.54","article-title":"Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus","volume":"8","author":"Lee","year":"2019","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2021.06.072_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2019.01.002","article-title":"Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus","volume":"163","author":"Kim","year":"2019","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.072_b0120","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41590-019-0320-6","article-title":"Human CD8(+) T cell cross-reactivity across influenza A B and C viruses","volume":"20","author":"Koutsakos","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2021.06.072_b0125","doi-asserted-by":"crossref","first-page":"22666","DOI":"10.1038\/srep22666","article-title":"Stalking influenza by vaccination with pre-fusion headless HA mini-stem","volume":"6","author":"Valkenburg","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2021.06.072_b0130","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.072_b0135","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines","volume":"110","author":"Tatsis","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2021.06.072_b0140","article-title":"Long-term maintenance of lung resident memory T cells is mediated by persistent antigen","author":"Uddback","year":"2020","journal-title":"Mucosal Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2021.06.072_b0145","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1128\/JVI.03101-13","article-title":"Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model","volume":"88","author":"Price","year":"2014","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.072_b0150","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.072_b0155","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1128\/jvi.68.1.530-534.1994","article-title":"The influenza-virus variant A\/FM\/1\/47-MA possesses single amino-acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth","volume":"68","author":"Smeenk","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.06.072_b0160","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1099\/0022-1317-69-11-2779","article-title":"Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines","volume":"69","author":"Chen","year":"1988","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2021.06.072_b0165","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.87.2.786","article-title":"Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins","volume":"87","author":"Kilbourne","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"32 Pt B","key":"10.1016\/j.vaccine.2021.06.072_b0170","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1016\/j.vaccine.2018.06.051","article-title":"Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen","volume":"36","author":"Price","year":"2018","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2021.06.072_b0175","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2217\/fmb-2019-0340","article-title":"Innate and adaptive immunity toward influenza B viruses","volume":"11","author":"Hensen","year":"2020","journal-title":"Future Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.072_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191574","article-title":"Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts","volume":"13","author":"Tutykhina","year":"2018","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2021.06.072_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022605","article-title":"Adenovirus-Vectored Drug-Vaccine Duo as a Rapid-Response Tool for Conferring Seamless Protection against Influenza","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.072_b0190","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1743-422X-10-244","article-title":"Cross-reactive human B cell and T cell epitopes between influenza A and B viruses","volume":"10","author":"Terajima","year":"2013","journal-title":"Virol J"},{"issue":"23","key":"10.1016\/j.vaccine.2021.06.072_b0195","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1128\/JVI.75.23.11392-11400.2001","article-title":"Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells","volume":"75","author":"Wedemeyer","year":"2001","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.06.072_b0200","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1084\/jem.188.9.1705","article-title":"Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations","volume":"188","author":"Selin","year":"1998","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.072_b0205","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1038\/s41467-020-17972-1","article-title":"A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"issue":"7830","key":"10.1016\/j.vaccine.2021.06.072_b0210","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"issue":"10240","key":"10.1016\/j.vaccine.2021.06.072_b0215","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.06.072_b0220","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4049\/jimmunol.158.3.1222","article-title":"Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in immunocompetent, T cell-depleted, \u03b22-microglobulin-deficient, and J chain-deficient mice","volume":"158","author":"Epstein","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2021.06.072_b0225","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.4049\/jimmunol.143.9.3007","article-title":"Identification and characterization of T-helper epitopes in the nucleoprotein of influenza A virus","volume":"143","author":"Gao","year":"1989","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.072_b0230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1074-7613(00)80161-2","article-title":"Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses","volume":"12","author":"Chen","year":"2000","journal-title":"Immunity"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:57:23Z","timestamp":1759402643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21008331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":46,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0264410X21008331"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}